Nicosia, Cyprus, 6th Nov 2026 – Cyprus IVF Centre has shared patient information explaining why two embryos that receive the same grade do not necessarily have the same potential.

Embryo grading is based on visible characteristics, including cell development and morphology. It provides valuable information about embryo quality during IVF treatment.

Embryo grading assesses an embryo’s appearance and development; it does not determine its chromosomal status. Genetic testing, where clinically indicated, evaluates a different aspect of the embryo and likewise cannot guarantee implantation or treatment success.

However, grading cannot fully predict an embryo’s developmental potential or implantation outcome. Even embryos with the same grade may behave differently, as factors beyond their appearance can influence development.

At Cyprus IVF Centre, the embryology team considers embryo grading alongside other relevant developmental and clinical information when assessing embryos for treatment.

Embryo grading supports the assessment of embryos. It does not guarantee implantation or treatment success.

“Two embryos can receive the same grade and still develop differently. Grading gives our embryology team valuable information, which we consider alongside other developmental and clinical information when assessing embryos. Embryo grading is an important part of the picture, but never the whole picture.”

— Ümit İnak, Director, Cyprus IVF Centre

Patients considering treatment are welcome to ask the team how their embryos will be assessed and what grading means for their own treatment. More information is available at:

embryo grading in IVF

Medically reviewed by the Cyprus IVF Centre Medical and Embryology Team, 5 November 2026

About Cyprus IVF Centre

Cyprus IVF Centre, home of Team Miracle, is an IVF and fertility clinic in Cyprus providing assisted reproductive treatment for UK and international patients. Fertility care is supported by clinical and embryology teams, with laboratory processes forming an integral part of its treatment services.

Media Contact

Organization: Team Miracle – Cyprus IVF Centre

Contact Person: Team Miracle – Cyprus IVF Centre

Website: https://cyprusivfcentre.com/

Email: Send Email

City: Nicosia

Country: Cyprus

Release id: 50535

View source version on King Newswire:
Cyprus IVF Centre Explains Why Similarly Graded Embryos May Develop Differently

Brentwood, Tennessee, USA, November 6th, 2026, FinanceWire

Canary Capital Group LLC (“Canary Capital”), a digital asset investment management firm, today announced the launch of the Canary Staked INJ ETF (Ticker: INJC), listed on Nasdaq. The Fund seeks to provide exposure to the price of INJ, the native token of the Injective blockchain network. In addition, the Fund also seeks to earn additional INJ through participation in the Injective network’s proof-of-stake validation process, with net staking rewards reflected in the Fund’s net asset value. 

“The Canary Staked INJ ETF gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards,” said Steven McClurg, CEO of Canary Capital. “Injective was designed from the ground up for trading, tokenization, markets, and financial applications. We believe investors are increasingly looking past the largest digital assets and toward the specialized networks building the next generation of on-chain financial infrastructure.” 

Injective is a Layer-1 blockchain designed to serve as the technological foundation for on-chain finance. Its purpose-built architecture offers developers pre-built, plug-and-play financial modules, including a fully onchain order book exchange module, enabling rapid development of tokenization, trading, derivatives, and other financial applications. INJ is used to secure the network through staking, to participate in governance, and to pay transaction and trading fees. 

The network also features a unique Community Buyback mechanism that regularly removes INJ from circulation using a portion of revenue generated by applications on the network. Injective has tokenized over $1 Billion in assets to date*, ranking it among the top blockchains for Real-World Assets (RWAs). As of October 22nd, 2026, Injective had processed more than 3.13 billion transactions and permanently burned more than 7.27 million INJ (~$58 million USD) across its monthly token buybacks. In addition, the analytics platform Token Terminal reports approximately 257,300* monthly active addresses on Injective. 

Recent upgrades include Injective Mint, which enables institutions to issue and manage tokenized assets with controls over ownership and transfers. Injective also showcased CypherOS which provides a full stack privacy platform capable of enabling confidential trading, transactions and tokenization. Also, over $25 million* of the native USDC stablecoin has been issued on Injective to support payments and settlement across the network. 

“Investors can now gain exposure to INJ through the brokerage accounts they already use,” said Eric Chen, Co-Founder of Injective Foundation. “We built Injective to bring financial markets onchain. Canary’s launch connects that mission to a broader base of investors, giving them a familiar way to access the asset that powers Injective.” 

For more information on INJC, click here.

Media Contacts 

Canary Capital 

media@canaryetfs.com 

About Canary Capital 

Canary Capital is an investment management firm that blends rigorous risk management, strategic foresight, and innovative thinking to deliver private placement strategies, crypto hedge fund solutions, treasury management solutions, and publicly traded funds, with a focus on enterprise technology. 

About Injective: 

Injective is the first blockchain purpose-built for finance, enabling users, institutions, and AI agents to trade, tokenize, and transact at scale. Proudly made in America, Injective provides foundational blockchain infrastructure for global markets, with embedded financial primitives spanning stablecoins, real-world assets, payments, and programmable perpetuals through a unified onchain engine. Injective is used by Fortune 500 companies, banks, fintechs, and governments to power an open economy where any asset can be accessed anytime, from anywhere. Builders can deploy across multiple virtual machines like EVM (Ethereum Virtual Machine) and WASM (WebAssembly), connect to native financial modules, and launch markets with deep liquidity from day one. INJ is the native token powering the rapidly growing Injective ecosystem and the new internet economy. 

*As of October 2026 

USDC – USDC is a stable digital dollar enabling fast, cheap, global blockchain transactions. 

The Canary Staked INJ ETF (Ticker: INJC) is an exchange-traded product that is not registered under the Investment Company Act of 1940 (the “1940 Act”) and therefore is not subject to the same regulations and protections as ETFs and mutual funds registered under the 1940 Act. Investing involves risk, including the possible loss of principal. An investment in INJC is subject to a high degree of risk and heightened volatility and is not suitable for investors who cannot afford the loss of their entire investment.

The Fund’s investment objectives, risks, charges and expenses should be considered before investing. The prospectus contains this and other important information, and it may be obtained at https://canaryetfs.com/INJC/prospectus/. Read it carefully before investing. 

An investment in INJC is not a direct investment in INJ. Staking rewards are not indicative of the Fund’s performance, are not guaranteed, and may change frequently, including experiencing significant declines. Digital assets, such as INJ, are a relatively new asset class, and the market for digital assets is subject to rapid changes and uncertainty. Digital assets are largely unregulated and digital asset investments may be more susceptible to fraud and manipulation than more regulated investments. 

INJC is subject to rapid price swings, including as a result of actions and statements by influencers and the media, change of assets, and other factors. There is no assurance that INJC will maintain its value over the long-term. 

Staking provides the Trust with the opportunity to create and earn additional INJ. The Trust will be entitled to all INJ generated by the Trust’s staking, after deduction of certain staking-related expenses. This additional INJ will increase the net assets of the Trust, benefiting Shareholders. 

Certain of such INJ may be treated as income to the Trust and may be held for future distribution to Shareholders, subject to procedures and requirements disclosed elsewhere in the Prospectus. 

Staking comes with a risk of loss of INJ. None of the Fund’s assets, including any staked assets, are subject to the protections enjoyed by depositors with Federal Deposit Insurance Corporation (“FDIC”) or Securities Investor Protection Corporation (SIPC) member institutions. The staked assets may also be subject to “slashing” penalties. Slashings occur when a validator attests to two different histories of the chain and penalties occur when a validator is offline for a prolonged period of time. The Fund itself will not engage in staking activities, including the operation of a validator node. Instead, the staking program will be administered by the Fund’s sponsor, who will utilize service providers including the custodians and staking providers. While the Fund’s sponsor does not expect the activities of the staking providers to result in slashing penalties, there can be no guarantee that slashing penalties will not occur. Furthermore, the custodians’ and staking providers’ liability to the Fund for the actions associated with the Staking Program is limited, and the custodians and staking providers may lack the assets or insurance in order to support the recovery of any losses incurred. Accordingly, there can be no guarantee that the Fund would recover any of its staked assets, or the value thereof, if it is subject to slashing or penalties. 

The Fund is new with a limited operating history. 

Paralel Distributors LLC, Marketing Agent. Paralel is unaffiliated with Canary Capital.

Contact

Sarah Cohen
sarah@sjc-pr.com

Fomboni, Comoros, November 6th, 2026, FinanceWire

FX Junction has published findings from a review of copy-trading activity on its marketplace, revealing that investors tend to follow traders with longer verified trading histories rather than those with the highest returns. The review highlights the importance of established trading records in investor decisions and provides insight into copy-trading behavior across the platform.

In copy trading, also called social trading, an investor links their own brokerage account to the account of another trader, known as a signal provider. From that point, every position the chosen trader opens is mirrored automatically in the investor’s account, scaled to the amount the investor has allocated. The investor’s money never leaves their own broker; what is shared is the trading decision, not the capital.

Across the platform’s verified signal providers, the distribution of copying activity is the point. Fewer than six in ten of them have attracted copiers; the rest have none.

Among those who are copied, the allocation runs against the return table. The five best-performing accounts on the platform, with total returns between 197 and 273 percent, together account for less than half a percent of all copying links. Their verified track records run from under seven months to just over fifteen. Accounts ranked below them returning 192 and 182 percent hold more than a quarter of all copying links on the platform and their verified histories are more than three times longer than the longest record among the top five.

Measured Across The Whole Marketplace, The Pattern Holds:

Length of record: providers with at least one copier have a median verified history of 21.6 months. Providers with no copiers have a median of 8.8 months.

Returns: the median total return is 25.2 percent for copied providers and 26.8 percent for providers with no copiers – effectively the same.

Own capital at stake: the median account equity of a copied provider is 25,237 US dollars, against 3,741 US dollars for providers with no copiers.

The platform’s wider counters stood at 41,008 registered members, 26,261,890 trades executed and 12,681 linked trading accounts as of 4 November 2026. Member funds always remain with the trader’s own broker. FX Junction does not hold client capital.

About FX Junction

The investment and trading platform FX Junction is one of the world’s leading social trading networks. In the area of CFDs and forex, FX Junction had already established itself as one of the global leaders among social platforms for traders.

FX Junction was founded in 2011. The company’s launch was backed by a Swiss investor through Pine Group SA, and its U.S. expansion led by Ryan Novak.

For more information about the company, visit: https://www.fxjunction.com

Risk Warning

FX Junction does not provide investment advice and individual traders should make their own decisions or seek independent advice. The value of investment can go down as well as up and may receive back less than the original investment. 

Trading in Leverage products carries a high level of risk and may not be suitable for all investors. Past performance of an investment is no guide to its performance in the future. Investments, or income from them, can go down as well as up. May not necessarily get back the amount that invested. All opinions, news, analysis, prices or other information contained in the communication and on the website, are provided as general market commentary and do not constitute investment advice, nor a solicitation or recommendation to buy or sell any financial instruments or other financial products or services.

Contact

Team of analysts
FX Junction
Marketing@fxjunction.com